Geode Capital Management
DMAA

Geode Capital Management’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

Geode Capital Management’s Portfolio DMAA Stock Details DMAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$663K Hold
62,273
– – ﹤0.01% 3494
2026
Q1 		$654K Buy
62,273
+16,625
+36% +$174K ﹤0.01% 3494
2025
Q4 		$473K Hold
45,648
– – ﹤0.01% 3604
2025
Q3 		$469K Hold
45,648
– – ﹤0.01% 3648
2025
Q2 		$466K Buy
45,648
+186
+0.4% +$1.88K ﹤0.01% 3576
2025
Q1 		$456K Buy
+45,462
New +$455K ﹤0.01% 3576

Other funds holding DMAA

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.69% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.69% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.5% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.76B AUM 23.76% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Geode Capital Management's DMAA Position: Q2 2026 in Review

Geode Capital Management held its Drugs Made In America Acquisition Corp (DMAA) position steady in Q2 2026 at 62,273 shares worth $663K. The position accounts for ﹤0.01% of the portfolio, ranked #3494.

Geode Capital Management first reported a position in DMAA in Q1 2025 and has held it in 6 quarters since. 18 funds tracked by Wall St. Rank hold DMAA as of Q2 2026.

  • Geode Capital Management held 62,273 shares of Drugs Made In America Acquisition Corp worth $663K as of Q2 2026.
  • Geode Capital Management left its Drugs Made In America Acquisition Corp share count unchanged in Q2 2026.
  • Drugs Made In America Acquisition Corp made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3494 holding.
  • Geode Capital Management first reported a position in Drugs Made In America Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
  • 18 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.